Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2017 | 09-2007 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,640 | N/A | N/A | N/A | -53,430 |
| Depreciation Amortization | 48 | N/A | N/A | N/A | 64,800 |
| Accounts payable and accrued liabilities | -270 | N/A | N/A | N/A | N/A |
| Other Working Capital | -430 | N/A | N/A | N/A | -410 |
| Other Operating Activity | 10,867 | 0 | 0 | 0 | -1,510 |
| Operating Cash Flow | $-3,425 | $N/A | $N/A | $N/A | $9,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | N/A | N/A | N/A | -1,660 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5,350 |
| Investing Cash Flow | $-122 | $N/A | $N/A | $N/A | $-7,010 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,358 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,042 | 0 | 0 | 0 | 5,980 |
| Financing Cash Flow | $7,323 | $N/A | $N/A | $N/A | $5,980 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -70 |
| Beginning Cash Position | 261 | N/A | N/A | N/A | 30,600 |
| End Cash Position | 4,036 | N/A | N/A | N/A | 38,960 |
| Net Cash Flow | $3,776 | $N/A | $N/A | $N/A | $8,350 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,425 | N/A | N/A | N/A | 9,450 |
| Capital Expenditure | -122 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,548 | 0 | 0 | 0 | 9,450 |